Life is hectic, we know, so here’s a recap of the Healthcare Weekly Hot Topics you can’t afford to miss:
1) Furor Over Drug Prices Puts Patient Advocacy Groups in Bind. The New York Times, September 27, 2016.
Patient advocacy groups have not spoken out against the cost of drugs, because many of the groups receive donations from companies behind the drugs.
2) GAO slams HHS in health IT cybersecurity report. Modern Healthcare, September 26, 2016.
The Government Accountability Office released a report on cybersecurity preparedness and threats in health information technology.
3) Are You Fit for Surgery? The Wall Street Journal, September 26, 2016.
More hospitals are asking the question before patients undergo elective procedures.
4) Drug databases are no panacea for opioid crisis. Politico, September 27, 2016.
Prescription drug monitoring programs have not helped to address addictions as a disease.
5) Mylan’s EpiPen Pretax Profits 60% Higher Than Number Told to Congress. The Wall Street Journal, September 26, 2016.
Mylan clarified the profit it said it made from the EpiPen drug after conveying a different figure to Congress.
Do you have questions about healthcare issues? We can help. For assistance, CLICK HERE.
Get “News You Can Use” delivered directly to your e-mail inbox. CLICK HERE TO SUBSCRIBE.
P.S. If you or your patients are interested in consumer healthcare issues, check out myhealthspin.com.